Samuel Agresta - 10 Jun 2021 Form 4 Insider Report for INFINITY PHARMACEUTICALS, INC. (INFI)

Role
Director
Signature
/s/ Samuel Agresta
Issuer symbol
INFI
Transactions as of
10 Jun 2021
Transactions value $
$0
Form type
4
Filing time
11 Jun 2021, 16:16:39 UTC
Next filing
28 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INFI Stock Option (right to buy) Award $0 +30,000 $0.000000 30,000 10 Jun 2021 Common Stock 30,000 $3.43 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests over a period of one year in equal quarterly installments beginning at the end of the first quarter after the date of grant, provided that the holder continues to serve as a director of the issuer.